Publicly traded KGaA | |
Traded as | : MRK |
Industry |
Chemicals pharmaceuticals |
Founded | 1668 |
Founder | Friedrich Jacob Merck |
Headquarters | Darmstadt, Germany |
Area served
|
Worldwide |
Key people
|
Stefan Oschmann (CEO and Chairman of the executive board), Wolfgang Büchele (Chairman of the supervisory board) |
Products | Liquid crystals, life science and performance chemicals, over-the-counter medicines, small molecules and biopharmaceuticals |
Revenue | €12,844.7 million (2015) |
Total assets | $42.13 billion (2016) |
Number of employees
|
Ca. 50,000 (2016) |
Website | www |
The Merck Group, branded and commonly known as Merck, is a German multinational chemical, pharmaceutical and life sciences company headquartered in Darmstadt, with around 50,000 employees in around 70 countries. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies in the world.
Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing. Merck pioneered the commercial manufacture of morphine in the 19th century and for a time held a virtual monopoly on cocaine.
Merck was privately owned until going public on the in 1995, and is listed on the DAX index of Germany's top companies. The Merck family still controls a majority 70.3% of the company's shares. The Merck Group includes around 250 companies in 180 countries; the current main parent company of the group, since 1995, is named Merck KGaA, and is itself mainly owned by the former main parent company, E. Merck oHG, which now operates as a holding company.
The American pharmaceutical company Merck & Co. was established as a subsidiary of Merck in 1891, but became an independent company in 1917. It is known as MSD (Merck Sharp and Dohme) outside of North America. The original Merck of Darmstadt holds the rights to the name Merck in all countries except the U.S. and Canada, where it is known as EMD (Emanuel Merck, Darmstadt). In 2015 Merck adopted a new uniform brand identity for all its subsidiaries, and the company has stressed its intention to protect the brand of "the real Merck" globally and initiated litigation against its former subsidiary over use of the name.